title: Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence.
abstract: Studies of associations between perioperative blood transfusions and later recurrence of solid tumors have yielded conflicting results. A previous analysis of transfused patients suggested that recurrence was associated with transfusion of whole blood as opposed to red blood cell concentrates. Additional analyses were performed on patients with cancers of the colon, rectum, cervix, and prostate to determine if patients receiving whole blood, red blood cells only, or no transfusions had differing outcomes. Patients receiving 1 unit or more of whole blood had uniformly poor outcomes compared with nontransfused patients (p less than 0.001). In contrast, patients receiving only red blood cells had progressively worse recurrence and death rates with increasing numbers of transfusion, suggesting the presence of a dose-effect relationship. Employing multivariate techniques, blood transfusion of less than or equal to 3 units that included any whole blood were independently and significantly associated with earlier recurrence (p = 0.003) and death due to cancer (p = 0.02). Transfusions of less than or equal to 3 units of blood comprised solely of red blood cell concentrates were associated with no greater risk of recurrence than that seen in patients receiving no transfusion (p = 0.50). These results provide a potential explanation for the disparate results reported in studies of blood transfusion and cancer outcome. The marked difference in outcome seen between patients receiving a few units of red blood cells and comparable patients receiving even one unit of whole blood are consistent with the hypothesis that transfusion of stored blood plasma causes earlier tumor recurrence in some instances. Strategies for reducing these risks might include avoidance of whole blood transfusions when only 1-3 units are required, more conservative transfusion practice, use of autologous blood transfusions, and perhaps, use of red blood cells washed free of plasma and white cell debris. Clinical trials to test these hypotheses are urgently needed.
authors: Department of Pathology, University of Rochester Medical Center, NY 14642.
authors: N
authors: N
authors: Blumberg
authors: J
authors: J
authors: Heal
authors: C
authors: C
authors: Chuang
authors: P
authors: P
authors: Murphy
authors: M
authors: M
authors: Agarwal
mesh_terms: D003110:Colonic Neoplasms / Q000628:therapy*; D017707:Erythrocyte Transfusion; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000209:etiology*; D011471:Prostatic Neoplasms / Q000628:therapy*; D012004:Rectal Neoplasms / Q000628:therapy*; D012307:Risk Factors; D065227:Transfusion Reaction; D002583:Uterine Cervical Neoplasms / Q000628:therapy*